Drug intelligence / Profile preview

sulfated hyaluronic acid

Development stage
Preclinical
Lead developer
University of Macau
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

Sulfated hyaluronic acid (sHA) is a chemically modified derivative of native hyaluronic acid (HA) characterized by the introduction of sulfate groups onto its backbone. This modification increases its negative charge density, which significantly enhances its resistance to hyaluronidase-mediated enzymatic degradation and improves its water-binding capacity. Sulfated hyaluronic acid mimics naturally occurring sulfated glycosaminoglycans (such as heparan sulfate) and exhibits high-affinity electrostatic interactions with various heparin-binding growth factors and cytokines, including VEGF-A, FGF2, TGF-β1, and IL-4. These interactions enable sHA to modulate inflammatory responses, promote angiogenesis, and regulate extracellular matrix remodeling. Developed by the University of Macau, Zhuhai UM Science and Technology Research Institute, and Xiamen Humanity Hospital, sulfated hyaluronic acid is being evaluated in clinical trials as a topical cream or gel for burn wound healing and scar prevention.

Other names
CLEANSCARS-HAsHAsulfated hyaluronansulfated sodium hyaluronate
02

Targets

CD44 (CD44 antigen)FGF2HYAL1 (Hyaluronidase-1)HYAL2 (Hyaluronidase-2)IL-4 (Interleukin 4)TGFBR1TGFB1 (Transforming growth factor Beta-1 proprotein)VEGFA (Vascular endothelial growth factor A)

Beyond the preview

Go deeper on sulfated hyaluronic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfated hyaluronic acid.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call